DRI Healthcare Trust Fundamental Analysis (TSX: DHT-U.TO)
DRI Healthcare Trust Fundamental Analysis (TSX: DHT-U.TO)
DRI Healthcare Trust (TSX: DHT-U.TO) shows weak financial fundamentals with a PE ratio of -16.62, profit margin of -21.59%, and ROE of -10.07%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -7.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze DHT-U.TO's fundamental strength across five key dimensions:
Efficiency Score
WeakDHT-U.TO struggles to generate sufficient returns from assets.
Valuation Score
ExcellentDHT-U.TO trades at attractive valuation levels.
Growth Score
ModerateDHT-U.TO shows steady but slowing expansion.
Financial Health Score
ModerateDHT-U.TO shows balanced financial health with some risks.
Profitability Score
WeakDHT-U.TO struggles to sustain strong margins.
Key Financial Metrics
Is DHT-U.TO Expensive or Cheap?
P/E Ratio
DHT-U.TO trades at -16.62 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, DHT-U.TO's PEG of 0.01 indicates potential undervaluation.
Price to Book
The market values DRI Healthcare Trust at 1.64 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.13 times EBITDA. This is generally considered low.
How Well Does DHT-U.TO Make Money?
Net Profit Margin
For every $100 in sales, DRI Healthcare Trust keeps $-21.59 as profit after all expenses.
Operating Margin
Core operations generate 33.56 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-10.07 in profit for every $100 of shareholder equity.
ROA
DRI Healthcare Trust generates $-4.49 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
DRI Healthcare Trust generates strong operating cash flow of $102.08M, reflecting robust business health.
Free Cash Flow
DRI Healthcare Trust produces free cash flow of $16.63M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.30 in free cash annually.
FCF Yield
DHT-U.TO converts 2.33% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-16.62
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.009
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.64
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.51
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.01
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.94
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.10
vs 25 benchmark
ROA
Return on assets percentage
-0.04
vs 25 benchmark
ROCE
Return on capital employed
0.07
vs 25 benchmark
How DHT-U.TO Stacks Against Its Sector Peers
| Metric | DHT-U.TO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -16.62 | 21.27 | Better (Cheaper) |
| ROE | -10.07% | 664.00% | Weak |
| Net Margin | -21.59% | -735.00% (disorted) | Weak |
| Debt/Equity | 1.01 | 0.80 | Weak (High Leverage) |
| Current Ratio | 3.94 | 910.47 | Strong Liquidity |
| ROA | -4.49% | 4469143.00% | Weak |
DHT-U.TO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews DRI Healthcare Trust's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical